Impact of Estrogen Use on Decline in Cognitive Function in a Representative Sample of Older Community-resident Women
The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
The authors investigated whether postmenopausal estrogen use helps to maintain cognitive function; a brief screen, the Short Portable Mental Status Questionnaire (SPMSQ), was used. Information was gathered from a stratified, random sample of 1,907 African-American and White women (aged 65–100 years) participating in the longitudinal Duke Established Populations for Epidemiologic Studies of the Elderly project carried out in five urban and rural counties of North Carolina. All women were cognitively unimpaired in 1986–1987 and were evaluated 3 and 6 years later. Decline in cognitive function was measured as an increase of two or more errors on the SPMSQ and crossing of an SPMSQ threshold indicative of cognitive impairment. Recency and continuity of estrogen use were measured. Univariate analyses indicated that recent (crude odds ratio = 0.42, 95% confidence interval: 0.21, 0.86) and continuous (crude odds ratio = 0.32, 95% confidence interval: 0.13, 0.81) estrogen use reduced the risk of cognitive decline but not of cognitive impairment. After adjustment for demographic and health characteristics, protective effects became nonsignificant. While postmenopausal use of estrogen may be protective for Alzheimer's disease, current findings based on a brief cognitive screen suggest that it is not protective for cognitive decline related to aging.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Strachan, M. W. J., Deary, I. J., Ewing, F. M. E., & Frier, B. M. (1997) · Diabetes Care · doi:10.2337/diacare.20.3.438 · Cited by 529 · cited 1×
“... (26, 27)); selected medications that may influence cognitive impairment (thyroid, benzodiazepine, nonsteroidal anti-inflammatory drugs (28‐31)) or that are taken for one of the same reasons as estrogen (e.g., calcium); health conditions (self-report of physician-diagnosed stroke, diabetes, hip fracture, other brok…”
BackgroundCognitive function in nondemented older women who took estrogen after menopause
Jacobs, D. M., Tang, M.-X., Stern, Y., Sano, M., Marder, K., Bell, K. L., Schofield, P., Dooneief, G., Gurland, B., & Mayeux, R. (1998) · Neurology · doi:10.1212/wnl.50.2.368 · Cited by 332
Disability and cognitive impairment in the elderly
Barberger-Gateau, P., & Fabrigoule, C. (1997) · Disability and Rehabilitation · doi:10.3109/09638289709166525 · Cited by 158 · cited 1×
“... (e.g., calcium); health conditions (self-report of physician-diagnosed stroke, diabetes, hip fracture, other broken bones, arthritis (information obtained at wave 2 only), heart attack, hypertension, incontinence, self-rated health (32)); health status as assessed by using the abbreviated Rosow-Breslau physical he…”
MethodHebert, L. E., Scherr, P. A., Beckett, L. A., Albert, M. S., Rosner, B., Talor, J. O., & Evans, D. A. (1993) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a116749 · Cited by 128
Cited by
Estrogen and cognitive functioning in women
Sherwin, B. B. (2003) · Endocrine Reviews · doi:10.1210/er.2001-0016 · Cited by 560
Steroid hormones and neurosteroids in normal and pathological aging of the nervous system
Schumacher, M., Weill-Engerer, S., Liere, P., Robert, F., Franklin, R. J. M., Garcia-Segura, L. M., Lambert, J. J., Mayo, W., Melcangi, R. C., Parducz, A., et al. (2003) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2003.09.004 · Cited by 300
Sherwin, B. B., & Henry, J. F. (2008) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2007.08.002 · Cited by 282
Fonda, S. J., Bertrand, R., O'Donnell, A., Longcope, C., & McKinlay, J. B. (2005) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/60.3.385 · Cited by 129
Postmenopausal hormone therapy, timing of initiation, APOE and cognitive decline
Kang, J. H., & Grodstein, F. (2012) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2010.10.007 · Cited by 90
“In several studies, particularly population-based studies with great variation in socioeconomic status,(Fillenbaum et al., 2001; Yaffe et al., 2000) adjustment for confounding reversed or substantially attenuated any apparent cognitive benefits of hormone use.”
Background
Metadata
- Authors
- Fillenbaum, G. G., Hanlon, J. T., Landerman, L. R., & Schmader, K. E.
- Venue
- American Journal of Epidemiology
- Publisher
- Oxford University Press (OUP)
- Published
- 2001-01-15
- Volume
- 153
- Issue
- 2
- Pages
- 137-144
- ISSN
- 0002-9262 (ISSN-L)
- 1476-6256
- OpenAlex
- W2096619844
- Cited by
- 47
- References
- 4
- FWCI
- 5.18
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Impact of Estrogen Use on Decline in Cognitive Function in a Representative Sample of Older Community-resident Women. https://app.cochat.ai/papers/10.1093/aje/153.2.137
- The paper
- Fillenbaum, G. G., Hanlon, J. T., Landerman, L. R., & Schmader, K. E. (2001). Impact of Estrogen Use on Decline in Cognitive Function in a Representative Sample of Older Community-resident Women. American Journal of Epidemiology. https://doi.org/10.1093/aje/153.2.137
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.